Effect of Dapagliflozin for type 2 diabetes mellitus with fatty liver
Not Applicable
- Conditions
- type 2 DM patients with fatty liver
- Registration Number
- JPRN-UMIN000026549
- Lead Sponsor
- Kagawa prefectural central hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
patients with allergy for Dapagliflozin
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method